Additional file 2 of From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models

Additional file 2: Table S1. Potentially actionable copy number variants. Table S2. Germline pathogenic variants. Table S3. Functional roles of genes harboring germline pathogenic variants. Table S4. Somatic pathogenic single nucleotide variants and insertions/deletions. Table S5. Somatic copy number variants (CN=0 and CN>10). Table 6. Potentially therapeutically targetable somatic alterations. Table S7. Percentage of conserved somatic variants among patient's tumors and PDX/CPDX and 3D models.